compound 7 [PMID: 37428122]   Click here for help

GtoPdb Ligand ID: 12852

Compound class: Synthetic organic
Comment: This compound is a small molecule inhibitor of citrate transporter SLC13A5 [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 1
Rotatable bonds 6
Topological polar surface area 96.8
Molecular weight 432.85
XLogP 1.15
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC1=NC(=CC=C1C(C)N2CCC3=C(C2)C(=NC(=C3C#N)Cl)NCC#N)OC(F)F
Isomeric SMILES CC(N1CCC2=C(C1)C(NCC#N)=NC(Cl)=C2C#N)C3=C(C)N=C(OC(F)F)C=C3
InChI InChI=1S/C20H19ClF2N6O/c1-11-13(3-4-17(27-11)30-20(22)23)12(2)29-8-5-14-15(9-25)18(21)28-19(16(14)10-29)26-7-6-24/h3-4,12,20H,5,7-8,10H2,1-2H3,(H,26,28)
InChI Key ROHREYIOOKLOGX-UHFFFAOYSA-N
Bioactivity Comments
In vivo this compound dose-dependently decreased plasma triglyceride and cholesterol levels which had the effect of reducing hepatic steatosis, hypertriglyceridemia, and hypercholesterolemia in a relevant mouse model [1].
Selectivity at transporters
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
Na+/citrate cotransporter Hs Inhibitor Inhibition >7.3 pIC50 - 1
pIC50 >7.3 (IC50 <5x10-8 M) [1]
Description: In a 14C-citrate uptake assay